Ignite Creation Date:
2025-12-24 @ 12:34 PM
Ignite Modification Date:
2026-01-28 @ 12:44 PM
Study NCT ID:
NCT02629861
Status:
COMPLETED
Last Update Posted:
2021-11-09
First Post:
2015-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of 2 Dose Regimens of TEV-48125 Versus Placebo for the Preventive Treatment of Episodic Migraine
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Migraine | View |
Keywords: